ALK GENE MUTATION
Clinical trials for ALK GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ALK GENE MUTATION trials appear
Sign up with your email to follow new studies for ALK GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for ALK-Positive lung cancer
Disease control OngoingThis study tests a new drug combination for people with advanced ALK-positive non-small cell lung cancer who haven't had treatment yet. Participants will receive either the targeted drug brigatinib alone or brigatinib plus chemotherapy. The goal is to see if the combination helps…
Matched conditions: ALK GENE MUTATION
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Smartphone app and fitbit join forces to monitor lung cancer treatment side effects
Knowledge-focused OngoingThis study involves 30 adults with lung cancer who are taking oral targeted therapy (TKIs). Participants use a smartphone app, a Fitbit, and a smart pill cap for up to 24 weeks to track symptoms and medication use. The goal is to see if this remote system is practical and to guid…
Matched conditions: ALK GENE MUTATION
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC